市場調査レポート
商品コード
996709

医薬品添加剤の世界市場 (~2026年):製品 (有機化学品 (炭水化物 (糖 (デキストロース))・無機化学品)・機能性 (充填剤・希釈剤・コーティング・崩壊剤)・製剤区分 (錠剤・カプセル・局所剤・非経口剤)・地域別

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates [Sugar (Dextrose)], Inorganic Chemicals), Functionality (Fillers, Diluents, Coating, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral)-Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 295 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.85円
医薬品添加剤の世界市場 (~2026年):製品 (有機化学品 (炭水化物 (糖 (デキストロース))・無機化学品)・機能性 (充填剤・希釈剤・コーティング・崩壊剤)・製剤区分 (錠剤・カプセル・局所剤・非経口剤)・地域別
出版日: 2021年03月18日
発行: MarketsandMarkets
ページ情報: 英文 295 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

医薬品添加剤の市場規模は予測期間中5.8%のCAGRで推移し、2021年の79億米ドルから、2026年には106億米ドルの規模に成長すると予測されています。

世界的な医薬品需要の高まりが、添加剤の消費率を高めています。製品別では、有機化学品の部門が2020年に最大のシェアを示し、予測期間中も最大のシェアを維持する見通しです。

当レポートでは、世界の医薬品添加剤の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、特許動向、市場規模の推移・予測、製品・機能性・製剤区分・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 市場成長要因
    • 市場抑制要因
    • 市場機会
    • 市場課題
  • COVID-19の影響

第6章 産業考察

  • 産業動向
  • 規制分析
  • ポーターの分析
  • エコシステム
  • 特許分析
  • 貿易データ
  • 価格分析

第7章 市場分析・予測:製品別

  • 有機化学品
    • 油脂化学品
    • 炭水化物
    • 石油化学品
    • タンパク質
    • その他
  • 無機化学品
    • リン酸カルシウム
    • 金属酸化物
    • 岩塩
    • 炭酸カルシウム
    • 硫酸カルシウム
    • その他
  • その他

第8章 市場分析・予測:機能性別

  • フィラー・希釈剤
  • 懸濁剤・粘度剤
  • コーティング剤
  • バインダー
  • 香料・甘味料
  • 解体
  • 着色剤
  • 潤滑剤・滑剤
  • 防腐剤
  • 乳化剤
  • その他

第9章 市場分析・予測:製剤別

  • 経口剤
    • タブレット
    • カプセル
    • 液体製剤
  • 局所剤
  • 非経口剤
  • その他

第10章 市場分析・予測:地域・主要国別

  • 欧州
  • 北米
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 企業の地理的フットプリント
  • 競合リーダーシップマッピング
  • 新興企業:競合リーダーシップマッピング
  • 市場シェア分析
  • トップ企業の収益シェア分析
  • 製品フットプリント
  • 競合状況・動向

第12章 企業プロファイル

  • 主要企業
    • DUPONT DE NEMOURS, INC.
    • ROQUETTE FRERES
    • ASHLAND
    • EVONIK INDUSTRIES AG
    • BASF SE
    • KERRY GROUP PLC
  • その他の企業
    • CRODA INTERNATIONAL
    • ASSOCIATED BRITISH FOODS PLC
    • ARCHER DANI
目次
Product Code: PH 3047

The pharmaceutical excipeints market is projected to reach USD 10.6 billion by 2026 from USD 7.9 billion in 2021, at a CAGR of 5.8%. The rising global demand for pharmaceuticals has fueled the growth of drug production, increasing the excipient consumption rate. The discovery of increasingly lipophilic APIs, macromolecules, and biological actives has created the need for well-evaluated excipients and the development of new ones. The currently used excipients may not be sufficient to support the newly discovered actives. As a result, demand has grown for newer, improved drugs, which calls for the development of new drug delivery systems that can deal with the challenges of drug development, such as bioavailability, permeability, and poor solubility. These challenges can be addressed through functional excipients for manufacturing drugs, fueling the demand for pharmaceutical excipients.

Based on product, the organic chemicals segment holds the largest market share during the forecast period.

Based on product, the pharmaceutical excipients market is segmented into three major categories- organic chemicals, inorganic chemicals, and other chemicals. In 2020, the organic chemicals segment accounted for the largest market share. This segment is also projected to register the highest CAGR during the forecast period. In 2020, the organic chemicals segment accounted for the largest share of the pharmaceutical excipients market. The large share of this segment can be attributed to the use of these chemicals in a majority of pharmaceutical formulations.

Based on functionality, the fillers & dilluents is expected to have significant market size during the forecast period.

Based on functionality, pharmaceutical excipients are categorized into fillers & diluents, binders,

suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants,

lubricants & glidants, preservatives, emulsifying agents, and other functionalities. By functionality, fillers & diluents held the largest share in 2020. The demand for fillers and diluents is high as they are utilized in manufacturing tablets and capsules.

Based on formualtions, the oral formulations segment holds the largest market share during the forecast period.

Based on the formulation, the pharmaceutical excipients market is segmented into oral, topical,

parenteral, and other formulations. Oral formulations dominate this market due to their wide usage and

efficacy against many ailments. Healthcare professionals recommended antiviral drugs as the primary line of defense against COVID-19. Due to their effectiveness in resolving pneumonia and respiratory ailments caused by the virus, these drugs were prescribed in large numbers. Since they are produced in tablet form for oral consumption, the oral formulations market has received a significant boost.

Europe is expected to account for the largest share of the pharmaceutical excipeints market in 2020

In 2020, Europe accounted for the largest share of the pharmaceutical excipients market, followed by North America, the Asia Pacific, Latin America, and the Middle East & Africa. Many European countries are focusing their attention on the generics market due to the expiration of blockbuster drug patents in the coming years. As a result, the European region is expected to witness major growth in its generics market during the forecast period, which will propel the demand for pharmaceutical excipients. Increasing government initiatives in countries such as Germany, Italy, and Spain for reducing drug prices are expected to drive the market for generic drugs in these countries. The abovementioned factors, alongside increasing investments for the development of biologics and advanced dosage forms, will increase the demand for novel excipients and thereby aid the growth of the pharmaceutical excipients market in Europe.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the Pharmaceutical excipients market

The key players operating in the pharmaceutical excipeints market include Ashland Global Holdings (US), BASF SE (Germany), DuPont (US), Roquette Feres (France), Evonik Industries AG (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), and Croda International (UK). Other players in this market are Innophous Holdings (US), Kerry Group (Ireland), WACKER Chemie AG (Germany), Colorcon (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France).

Research Coverage:

The report analyzes the pharmaceutical excipients market and aims at estimating the market size and future growth potential of this market based on various segments such as product, functionality, formulations, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global pharmaceutical excipients market. The report analyzes this market by product, functionality and formulations
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global pharmaceutical excipients market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, functionality, formulations, and end user
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pharmaceutical excipients market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global pharmaceutical excipients market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 PHARMACEUTICAL EXCIPIENTS MARKET
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 BOTTOM-UP APPROACH
    • FIGURE 5 TOP-DOWN APPROACH
    • FIGURE 6 REVENUE SHARE ANALYSIS
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE PHARMACEUTICAL EXCIPIENTS MARKET
    • FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES OF THE PHARMACEUTICAL EXCIPIENTS INDUSTRY (2020-2026)
  • 2.3 DATA TRIANGULATION APPROACH
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 11 SCENARIOS FOR THE RECOVERY OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 12 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 ORGANIC CHEMICALS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL EXCIPIENTS MARKET

4 PREMIUM INSIGHTS

  • 4.1 PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW
    • FIGURE 17 GROWING PHARMACEUTICALS INDUSTRY COUPLED WITH ADVANCEMENTS IN FUNCTIONAL EXCIPIENTS ARE KEY FACTORS DRIVING MARKET GROWTH
  • 4.2 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC COUNTRIES TO SHOW THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 4.3 REGIONAL MIX: PHARMACEUTICAL EXCIPIENTS MARKET (2021-2026)
    • FIGURE 19 EUROPE TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD (2021-2026)
  • 4.4 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION AND COUNTRY (2020)
    • FIGURE 20 ORAL FORMULATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Growth of the pharmaceuticals market backed by functional excipients
    • FIGURE 22 GLOBAL PHARMACEUTICAL DRUG SALES (2008-2022)
      • 5.2.1.2 Surge in the generics market
    • TABLE 1 DRUG PATENT EXPIRY, BY YEAR
      • 5.2.1.3 Increasing uptake of biopharmaceuticals
      • 5.2.1.4 Rising adoption of orphan drugs
    • FIGURE 23 INCREASING PENETRATION OF ORPHAN DRUGS (2010-2024)
    • FIGURE 24 RISING NUMBER OF ORPHAN INDICATIONS APPROVED IN THE US
    • TABLE 2 KEY MARKET DRIVERS: IMPACT ANALYSIS
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Cost and time-intensive drug development process
      • 5.2.2.2 Increasing regulatory stringency
    • TABLE 3 KEY MARKET RESTRAINTS: IMPACT ANALYSIS
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Multifunctional excipients
    • TABLE 4 MULTIFUNCTIONAL EXCIPIENTS
      • 5.2.3.2 Shifting focus of pharmaceutical manufacturing to emerging countries
      • 5.2.3.3 Growth in the biosimilars market
    • FIGURE 25 TOTAL NUMBER OF NEW MOLECULAR ENTITY (NME) & NEW BIOLOGIC LICENSE APPLICATION (BLA) FILINGS AND APPROVALS IN THE US, 2006-2018
    • TABLE 5 CLINICAL STUDIES FOR BIOLOGICS & BIOSIMILARS (2017)
    • TABLE 6 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Safety and quality concerns
      • 5.2.4.2 Changing trade policies
    • TABLE 7 KEY MARKET CHALLENGES: IMPACT ANALYSIS
  • 5.3 COVID-19 IMPACT
    • FIGURE 26 INCREASE IN REVENUE, BY QUARTER
    • FIGURE 27 COVID-19 IMPACT ON SECTIONS OF THE PHARMACEUTICAL INDUSTRY

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • FIGURE 28 INCREASING FOCUS ON CO-PROCESSED EXCIPIENTS AND USE OF NANOTECHNOLOGY ARE THE LEADING TRENDS IN THE INDUSTRY
    • 6.2.1 RISING DEMAND FOR CO-PROCESSED EXCIPIENTS
    • TABLE 8 MARKETED CO-PROCESSED EXCIPIENTS
    • 6.2.2 IMPROVING EXCIPIENT CAPABILITIES USING NANOTECHNOLOGY
    • 6.2.3 INCREASING USE OF DIRECT COMPRESSION IN ORAL DOSAGE FORMULATIONS
    • 6.2.4 PHARMACEUTICAL EXCIPIENTS INFLUENCING THE COST OF PRODUCTION
  • 6.3 REGULATORY ANALYSIS
    • 6.3.1 NORTH AMERICA
      • 6.3.1.1 US
      • 6.3.1.2 Canada
    • 6.3.2 EUROPE
    • 6.3.3 ASIA PACIFIC
      • 6.3.3.1 Japan
      • 6.3.3.2 China
      • 6.3.3.3 India
  • 6.4 PORTER'S ANALYSIS
    • TABLE 9 PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.4.2 BARGAINING POWER OF SUPPLIERS
    • 6.4.3 BARGAINING POWER OF BUYERS
    • 6.4.4 THREAT OF SUBSTITUTES
    • 6.4.5 INTENSITY OF NEW ENTRANTS
  • 6.5 ECOSYSTEM ANALYSIS
  • 6.6 PATENT ANALYSIS
    • FIGURE 29 PATENT ANALYSIS: NUMBER OF PUBLICATIONS FOR THE PHARMACEUTICAL INDUSTRY
    • TABLE 10 PROMINENT PHARMACEUTICAL EXCIPIENT PATENTS
  • 6.7 TRADE DATA
  • 6.8 PRICING ANALYSIS
    • 6.8.1 US
    • 6.8.2 CHINA
    • 6.8.3 INDIA

7 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 11 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 12 PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.2 ORGANIC CHEMICALS
    • TABLE 13 ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 14 ORGANIC CHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.1 OLEOCHEMICALS
    • TABLE 15 OLEOCHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 16 OLEOCHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.1 Fatty alcohols
        • 7.2.1.1.1 Fatty alcohols are widely used as nonionic surfactants due to their amphipathic nature-a major driver for market growth
    • TABLE 17 FATTY ALCOHOLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.2 Mineral stearates
        • 7.2.1.2.1 Wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations to drive market growth
    • TABLE 18 MINERAL STEARATES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.3 Glycerin
        • 7.2.1.3.1 Extensive applications of glycerin to drive market growth
    • TABLE 19 GLYCERIN MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.1.4 Other oleochemicals
    • TABLE 20 OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.2 CARBOHYDRATES
    • TABLE 21 CARBOHYDRATES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 22 CARBOHYDRATES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.1 Sugars
    • TABLE 23 SUGARS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 24 SUGARS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.1.1 Actual sugars
    • TABLE 25 ACTUAL SUGARS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 26 ACTUAL SUGARS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
          • 7.2.2.1.1.1 Lactose
          • 7.2.2.1.1.1.1 Lactose is the most commonly used excipient in tablets and capsules
          • 7.2.2.1.1.2 Sucrose
          • 7.2.2.1.1.2.1 Sucrose is extensively used in oral pharmaceutical formulations
          • 7.2.2.1.1.3 Dextrose (D-Glucose)
          • 7.2.2.1.1.3.1 Dextrose has a wide range of applications in tablets and capsules
        • 7.2.2.1.2 Sugar alcohols
    • TABLE 27 SUGAR ALCOHOLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 28 SUGAR ALCOHOLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
          • 7.2.2.1.2.1 Mannitol
          • 7.2.2.1.2.1.1 Mannitol is widely used with moisture-sensitive active ingredients as it is non-hygroscopic in nature
          • 7.2.2.1.2.2 Sorbitol
          • 7.2.2.1.2.2.1 Sorbitol is one of the most widely used compression diluents for pharmaceutical formulations
          • 7.2.2.1.2.3 Other sugar alcohols
        • 7.2.2.1.3 Artificial sweeteners
          • 7.2.2.1.3.1 Aspartame is the most commonly used artificial sweetener
    • TABLE 29 ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.2 Cellulose
    • TABLE 30 CELLULOSE MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 31 CELLULOSE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.2.1 Microcrystalline cellulose
          • 7.2.2.2.1.1 Microcrystalline cellulose is the most widely used excipient in the direct compression method for tablets
    • TABLE 32 MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.2.2 Cellulose ethers
          • 7.2.2.2.2.1 Cellulose ethers are effective even at a lower concentration
    • TABLE 33 CELLULOSE ETHERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.2.3 CMC and croscarmellose sodium
          • 7.2.2.2.3.1 Multiple advantages of CMC and croscarmellose sodium make them the most widely used suspending agents in injectable preparations
    • TABLE 34 CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.2.4 Cellulose esters
          • 7.2.2.2.4.1 Cellulose esters enable the delivery of drugs in cellular membranes and the intracellular matrix
    • TABLE 35 CELLULOSE ESTERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.2.3 Starch
    • TABLE 36 STARCH MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 37 STARCH MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.3.1 Modified starch
          • 7.2.2.3.1.1 Modified starch is widely used in sustained-release tablets due to its cold-water swelling and gel barrier formation capabilities
    • TABLE 38 MODIFIED STARCH MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.3.2 Dried starch
          • 7.2.2.3.2.1 Dried starch is a strong binding and coating agent
    • TABLE 39 DRIED STARCH MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.2.3.3 Converted starch
          • 7.2.2.3.3.1 Converted starch is used as a molecular encapsulation agent and offers enhanced solubility and stability for drugs
    • TABLE 40 CONVERTED STARCH MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.3 PETROCHEMICALS
    • TABLE 41 PETROCHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 42 PETROCHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.3.1 Glycols
    • TABLE 43 GLYCOLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 44 GLYCOLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.3.1.1 Polyethylene glycol
          • 7.2.3.1.1.1 PEG is the excipient of choice in a large number of drug formulations due to its tunable properties and well-established safety profile
        • 7.2.3.1.2 Propylene glycol
          • 7.2.3.1.2.1 In high amounts, propylene glycol has been reported to be toxic among the pediatric population
      • 7.2.3.2 Povidones
        • 7.2.3.2.1 Rising demand for fast-dissolving tablets is expected to propel the growth of this segment
    • TABLE 45 POVIDONES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.3.3 Mineral hydrocarbons
    • TABLE 46 MINERAL HYDROCARBONS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 47 MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
        • 7.2.3.3.1 Petrolatum
          • 7.2.3.3.1.1 Petrolatum is commonly used in topical formulations
        • 7.2.3.3.2 Mineral waxes
          • 7.2.3.3.2.1 Mineral waxes are non-toxic and non-irritant in nature and are suitable for skin and eye preparations
        • 7.2.3.3.3 Mineral oils
          • 7.2.3.3.3.1 White mineral oils are good emollients, lubricating agents, and solvents
      • 7.2.3.4 Acrylic polymers
        • 7.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market growth
    • TABLE 48 ACRYLIC POLYMERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
      • 7.2.3.5 Other petrochemicals
    • TABLE 49 OTHER PETROCHEMICALS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • 7.2.4 PROTEINS
      • 7.2.4.1 Growing applications of proteins as carriers for microparticles and nanoparticles to drive market growth
    • TABLE 50 PROTEINS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.5 OTHER ORGANIC CHEMICALS
    • TABLE 51 OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 INORGANIC CHEMICALS
    • TABLE 52 INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 53 INORGANIC CHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.1 CALCIUM PHOSPHATE
      • 7.3.1.1 Chemical purity and low incompatibility with drugs aid their high usage in the pharmaceutical industry
    • TABLE 54 CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.2 METAL OXIDES
      • 7.3.2.1 Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth
    • TABLE 55 METAL OXIDES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.3 HALITES
      • 7.3.3.1 Increased utilization of halites in vaccines and controlled-release formulations is driving their demand in the market
    • TABLE 56 HALITES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.4 CALCIUM CARBONATE
      • 7.3.4.1 Properties such as short disintegration time and excellent mechanical strength for oral dosage formulations to drive the market
    • TABLE 57 CALCIUM CARBONATE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.5 CALCIUM SULFATE
      • 7.3.5.1 Calcium sulfate is a cost-effective, quality-enhancing diluent for solid dosage forms
    • TABLE 58 CALCIUM SULFATE MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.6 OTHER INORGANIC CHEMICALS
    • TABLE 59 OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 OTHER CHEMICALS
    • TABLE 60 OTHER CHEMICALS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

  • 8.1 INTRODUCTION
    • TABLE 61 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
  • 8.2 FILLERS & DILUENTS
    • 8.2.1 DILUENTS OFFER PROPERTIES SUCH AS IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO THE FINAL DOSE IN TABLETS
    • TABLE 62 PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 SUSPENDING & VISCOSITY AGENTS
    • 8.3.1 SUSPENSIONS OFFER ADVANTAGES SUCH AS DRUG STABILITY AND TASTE MASKING
    • TABLE 63 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 COATING AGENTS
    • 8.4.1 INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN THE PHARMA INDUSTRY TO DRIVE MARKET GROWTH
    • TABLE 64 PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 BINDERS
    • 8.5.1 BINDERS PROVIDE THE PROPERTIES OF FLUIDITY AND COMPRESSIBILITY ESSENTIAL FOR TABLET MANUFACTURING
    • TABLE 65 PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.6 FLAVORING AGENTS & SWEETENERS
    • 8.6.1 FLAVORING AGENTS ARE USED TO IMPROVE THE PALATABILITY OF DRUGS
    • TABLE 66 PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.7 DISINTEGRANTS
    • 8.7.1 DISINTEGRANTS ARE FORMULATED TO CAUSE A RAPID BREAK-UP OF SOLIDS DOSAGE FORMS
    • TABLE 67 PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.8 COLORANTS
    • 8.8.1 COLORING AGENTS ARE USED IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS
    • TABLE 68 PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.9 LUBRICANTS & GLIDANTS
    • 8.9.1 GLIDANTS IMPROVE THE FLOW PROPERTIES OF A FORMULATION BY REDUCING INTER-PARTICLE FRICTION AND COHESION
    • TABLE 69 PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.10 PRESERVATIVES
    • 8.10.1 BENZYL ALCOHOL IS A WIDELY USED PRESERVATIVE IN THE PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY
    • TABLE 70 PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.11 EMULSIFYING AGENTS
    • 8.11.1 USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS HELPS INCREASE API BIOAVAILABILITY
    • TABLE 71 PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.12 OTHER FUNCTIONALITIES
    • TABLE 72 OTHER FUNCTIONALITIES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

9 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION

  • 9.1 INTRODUCTION
    • TABLE 73 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
  • 9.2 ORAL FORMULATIONS
    • TABLE 74 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 9.2.1 TABLETS
      • 9.2.1.1 Tablets are the most widely used dosage forms
    • TABLE 76 TYPICAL COMPOSITION OF TABLETS
    • TABLE 77 PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 9.2.2 CAPSULES
    • TABLE 78 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 79 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2019-2026 (USD MILLION)
      • 9.2.2.1 Hard gelatin capsules
        • 9.2.2.1.1 Ease of manufacturing and versatility are driving the growth of the hard gelatin capsules market
    • TABLE 80 PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD GELATIN CAPSULES, BY COUNTRY, 2019-2026 (USD MILLION)
      • 9.2.2.2 Soft gelatin capsules
        • 9.2.2.2.1 Stability concerns with highly water-soluble compounds and compounds susceptible to hydrolysis have restricted market growth
    • TABLE 81 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT GELATIN CAPSULES, BY COUNTRY, 2019-2026 (USD MILLION)
    • 9.2.3 LIQUID FORMULATIONS
      • 9.2.3.1 Liquid formulations require no dissolution time and boast faster absorption from the stomach than tablets
    • TABLE 82 PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 TOPICAL FORMULATIONS
    • 9.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY ARE DRIVING THE DEMAND FOR EXCIPIENTS IN THIS SEGMENT
    • TABLE 83 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 PARENTERAL FORMULATIONS
    • 9.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE THE DEMAND FOR EXCIPIENTS
    • TABLE 84 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
    • TABLE 85 EXCIPIENTS USED IN PARENTERAL FORMULATIONS
    • TABLE 86 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.5 OTHER FORMULATIONS
    • TABLE 87 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2019-2026 (USD MILLION)

10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 88 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 EUROPE
    • 10.2.1 COVID-19 IMPACT ON THE EUROPEAN MARKET
    • FIGURE 30 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
    • TABLE 89 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 90 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 91 EUROPE: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 EUROPE: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 93 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 94 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.2.2 GERMANY
      • 10.2.2.1 Germany accounted for the largest share of the European pharmaceutical excipients market in 2020
    • TABLE 95 GERMANY: KEY MICROINDICATORS
    • TABLE 96 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 97 GERMANY: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 GERMANY: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 100 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.2.3 FRANCE
      • 10.2.3.1 Large geriatric population in the country to support market growth
    • TABLE 101 FRANCE: KEY MICROINDICATORS
    • TABLE 102 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 103 FRANCE: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 FRANCE: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 106 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.2.4 UK
      • 10.2.4.1 Growing adoption of generics and the development of novel multi-functional, co-processed excipients to drive market growth
    • TABLE 107 UK: KEY MICROINDICATORS
    • TABLE 108 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 109 UK: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 UK: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 112 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.2.5 SWITZERLAND
      • 10.2.5.1 Large volume of pharmaceuticals produced in Switzerland is a key factor driving market growth
    • TABLE 113 SWITZERLAND: KEY MICROINDICATORS
    • TABLE 114 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 115 SWITZERLAND: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 SWITZERLAND: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 118 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.2.6 ITALY
      • 10.2.6.1 Budgetary constraints and restricted healthcare spending to impede the growth of the Italian market
    • TABLE 119 ITALY: KEY MICROINDICATORS
    • TABLE 120 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 121 ITALY: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 ITALY: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 124 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.2.7 SPAIN
      • 10.2.7.1 High consumption of biologics to support market growth
    • TABLE 125 SPAIN: KEY MICROINDICATORS
    • TABLE 126 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 127 SPAIN: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 128 SPAIN: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 130 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.2.8 REST OF EUROPE
    • TABLE 131 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 132 ROE: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 ROE: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 135 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
  • 10.3 NORTH AMERICA
    • 10.3.1 COVID-19 IMPACT ON THE NORTH AMERICAN MARKET
    • FIGURE 31 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
    • TABLE 136 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 137 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 NORTH AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 NORTH AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 140 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 141 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.3.2 US
      • 10.3.2.1 The US dominates the North American market due to the increasing use of biologics and the increasing per capita pharmaceutical spending
    • TABLE 142 US: KEY MICROINDICATORS
    • TABLE 143 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 US: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 US: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 146 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 147 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.3.3 CANADA
      • 10.3.3.1 Strong growth of the emerging markets and slowdown in new product approvals to hamper the market growth in Canada
    • TABLE 148 CANADA: KEY MICROINDICATORS
    • TABLE 149 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 CANADA: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 CANADA: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 153 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 COVID-19 IMPACT ON THE APAC MARKET
    • FIGURE 32 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
    • TABLE 154 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 The rapid growth of Japan's geriatric population will greatly drive the demand for pharmaceuticals
    • TABLE 160 JAPAN: KEY MICROINDICATORS
    • TABLE 161 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 162 JAPAN: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 163 JAPAN: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 165 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.4.3 CHINA
      • 10.4.3.1 Emphasis on generics and off-patent drugs to drive the market in China
    • TABLE 166 CHINA: KEY MICROINDICATORS
    • TABLE 167 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 168 CHINA: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 169 CHINA: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 170 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 171 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 India is a leading producer of generics
    • TABLE 172 INDIA: KEY MICROINDICATORS
    • TABLE 173 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 174 INDIA: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 175 INDIA: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 177 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Thriving generic drug market to support the growth of pharmaceutical excipients market in South Korea
    • TABLE 178 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 SOUTH KOREA: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 180 SOUTH KOREA: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 181 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 182 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 183 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 ROAPAC: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 185 ROAPAC: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 186 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 187 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE ARE DRIVING MARKET GROWTH
    • 10.5.2 COVID-19 IMPACT ON THE LATAM MARKET
    • TABLE 188 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 189 LATIN AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 190 LATIN AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 192 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 UNSATURATED MARKETS IN THE REGION HAVE DRAWN THE ATTENTION OF GLOBAL PLAYERS
    • 10.6.2 COVID-19 IMPACT ON THE MEA MARKET
    • TABLE 193 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 MIDDLE EAST AND AFRICA: ORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 MIDDLE EAST AND AFRICA: INORGANIC CHEMICALS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 196 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019-2026 (USD MILLION)
    • TABLE 197 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
    • FIGURE 33 KEY PLAYER STRATEGIES
  • 11.2 COMPANY GEOGRAPHIC FOOTPRINT: PHARMACEUTICAL EXCIPIENTS MARKET
    • FIGURE 34 COMPANY GEOGRAPHIC FOOTPRINT: PHARMACEUTICAL EXCIPIENTS MARKET (2020)
  • 11.3 COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1 STARS
    • 11.3.2 EMERGING LEADERS
    • 11.3.3 PERVASIVE PLAYERS
    • 11.3.4 PARTICIPANTS
    • FIGURE 35 PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
  • 11.4 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
    • 11.4.1 PROGRESSIVE COMPANIES
    • 11.4.2 DYNAMIC COMPANIES
    • 11.4.3 STARTING BLOCKS
    • 11.4.4 RESPONSIVE COMPANIES
    • FIGURE 36 PHARMACEUTICAL EXCIPIENTS MARKET: START-UP COMPANY EVALUATION MATRIX (2020)
  • 11.5 MARKET SHARE ANALYSIS
    • FIGURE 37 PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
  • 11.6 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 38 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
  • 11.7 PRODUCT FOOTPRINT
  • 11.8 COMPETITIVE SITUATIONS AND TRENDS
    • TABLE 198 PRODUCT LAUNCHES (2017-2020)
    • TABLE 199 MERGERS & ACQUISITIONS (2017-2020)
    • TABLE 200 AGREEMENTS & PARTNERSHIPS (2017-2020)
    • TABLE 201 EXPANSIONS (2017-2020)
    • TABLE 202 OTHER DEVELOPMENTS (2017-2020)

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)**
    • 12.1.1 DUPONT DE NEMOURS, INC.
    • TABLE 203 DUPONT DE NEMOURS: BUSINESS OVERVIEW
    • FIGURE 39 DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT (2019)
    • 12.1.2 ROQUETTE FRERES
    • TABLE 204 ROQUETTE FRERES: BUSINESS OVERVIEW
    • 12.1.3 ASHLAND
    • TABLE 205 ASHLAND: BUSINESS OVERVIEW
    • FIGURE 40 ASHLAND: COMPANY SNAPSHOT (2020)
    • 12.1.4 EVONIK INDUSTRIES AG
    • TABLE 206 EVONIK INDUSTRIES: BUSINESS OVERVIEW
    • FIGURE 41 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2019)
    • 12.1.5 BASF SE
    • TABLE 207 BASF SE: BUSINESS OVERVIEW
    • FIGURE 42 BASF SE: COMPANY SNAPSHOT (2019)
    • 12.1.6 KERRY GROUP PLC
    • TABLE 208 KERRY GROUP: BUSINESS OVERVIEW
    • FIGURE 43 KERRY GROUP PLC: COMPANY SNAPSHOT (2019)
  • 12.2 OTHER PLAYERS
    • 12.2.1 CRODA INTERNATIONAL
    • TABLE 209 CRODA INTERNATIONAL: BUSINESS OVERVIEW
    • FIGURE 44 CRODA INTERNATIONAL: COMPANY SNAPSHOT (2019)
    • 12.2.2 ASSOCIATED BRITISH FOODS PLC
    • TABLE 210 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
    • FIGURE 45 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2020)
    • 12.2.3 ARCHER DANI